As some of you may have already heard, we got some good news recently: Brad had a PET scan a few weeks after returning from New York, and it was clear. Also, his recent blood tests have shown no traces of the Epstein-Barr virus that was causing his B-cell lymphoma.

As a result, the doctor in charge of the clinical trial in New York has moved him to the second phase of the trial: monitoring. This means he won’t need to return to New York in the near future, but that the treatment offered at Sloan-Kettering will still be available if the cancer should return. As part of the monitoring phase, he’ll be scanned periodically to check that he remains in remission.

We’re all deeply relieved that he has no active disease, is feeling relatively well, and is here in California instead of New York. He is now back to the long slow recovery that the new cancer diagnosis in the fall so rudely interrupted. Brad is able to see friends often (don’t hesitate to text or call Brad if you’d like to have lunch or coffee; his vision still isn’t up to checking email) and we are able to spend a lot of time together as a family—a boon for us all.